HSBC Holdings’s Biohaven BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$583K Sell
39,510
-5,605
-12% -$60.3K ﹤0.01% 2201
2026
Q1
$379K Buy
45,115
+20,949
+87% +$229K ﹤0.01% 2344
2025
Q4
$282K Buy
+24,166
New +$299K ﹤0.01% 2553
2025
Q2
Sell
-10,321
Closed -$242K 3038
2025
Q1
$242K Sell
10,321
-40
-0.4% -$1.41K ﹤0.01% 2513
2024
Q4
$380K Buy
10,361
+1,006
+11% +$46.9K ﹤0.01% 2344
2024
Q3
$473K Buy
9,355
+1,064
+13% +$41.4K ﹤0.01% 2045
2024
Q2
$286K Buy
8,291
+480
+6% +$19K ﹤0.01% 2316
2024
Q1
$427K Buy
+7,811
New +$387K ﹤0.01% 2183

Other funds holding BHVN

HSBC Holdings's BHVN Position: Q2 2026 in Review

HSBC Holdings reduced its Biohaven (BHVN) stake by 12% in Q2 2026, selling an estimated $60.3K and leaving 39,510 shares worth $583K. The position accounts for ﹤0.01% of the portfolio, ranked #2201.

HSBC Holdings first reported a position in BHVN in Q1 2024 and has held it in 8 quarters since. 292 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • HSBC Holdings held 39,510 shares of Biohaven worth $583K as of Q2 2026.
  • HSBC Holdings sold 5,605 Biohaven shares in Q2 2026, an estimated $60.3K.
  • Biohaven made up ﹤0.01% of HSBC Holdings's portfolio in Q2 2026, its #2201 holding.
  • HSBC Holdings first reported a position in Biohaven in Q1 2024 and has held it in 8 quarters since.
  • 292 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.